News

Your contact person

Manager PR & Communications Jan Phillip Denkers

Evotec to acquire Aptuit

Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) and Aptuit announced today that they have entered into a definitive agreement under which Evotec ...

Read more …

Evotec received funding from IFB Hamburg

Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today that the Company has been awarded a 'Programm für Innovation' ("PROFI") grant for ...

Read more …
Teaser

Infection Research at the Highest Level

On June 29th, the Centre for Structural Systems Biology celebrated its grand opening on the DESY Campus in Hamburg. In this new interdisciplinary research ...

Read more …
Teaser

4th Annual G20 BRAIN Initiative/Neuroscience-20 symposium

Fraunhofer IME Institute, Uskudar University , the Society for Brain Mapping and Therapeutics (SBMT), Brain Mapping Foundation (BMF), National Center for NanoBioElectronic (NCNBE) have ...

Read more …

Baltic Sea Region is frontrunner for eHealth

A very fruitful panel discussion took place on 14th of June within the 8th Annual Forum of the EU Strategy for the Baltic Sea ...

Read more …

Evotec achieves first milestone in Diabetes alliance with Sanofi

Hamburg, Germany 05 April 2017: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced that its strategic alliance (TargetBCD) with Sanofi in ...

Read more …
Foto: Topas Therapeutics GmbH

Paul Sekhri joins Topas Therapeutics as Chairman of the Board

Topas Therapeutics GmbH (“Topas”), a privately held biotech company pursuing a novel liver-based immune tolerance approach, today announced the election of Paul Sekhri as ...

Read more …

Indivumed Founder and CEO Recognized for Contribution to Liquid Biopsy Innovation

Hamburg, Germany, March 31, 2017– Indivumed, GmbH announces today that its Founder and Chief Executive Officer Hartmut Juhl, MD, surgical oncologist and cancer researcher ...

Read more …
Teaser

CMC Pharma and AmpTec close consulting agreement for API-mRNA production

CMC Pharma GmbH is a GMP service provider for pharmaceutical and life science companies as well as their suppliers. CMC Pharma offers FDA registration ...

Read more …

Haplogen´s novel antiviral target partnered with Evotec published in 'Nature'

On January 12th, 2017, Evotec AG announced a promising research result in the field of picornaviruses published in a scientific article by Dr Thijn ...

Read more …

Northwell Health Partners with Indivumed to Create a Cancer Research Biobank

Partnering with patients and physicians to collect and analyze biospecimens of cancer tissues will advance understanding of the genetics of cancer, making possible new ...

Read more …

Indivumed joins Blood Profiling Atlas in Cancer (Blood PAC)

Indivumed GmbH, a global oncology research company with a unique global clinical network, bio repository and cancer data base will contribute research expertise and ...

Read more …